Chhabra and his colleagues examined the anonymous medical records of over 50,000 people who received surgery (either a sleeve gastrectomy or gastric bypass) or GLP-1 therapy (either semaglutide or tirzepatide) through NYU Langone Health or NYC Health + Hospitals between 2018 and 2024
That includes whether they're currently using medications, transitioning off medications or simply inspired to adopt healthier eating patterns
Light and transmission electron microscopy observations
Optimizing weight loss outcomes with tirzepatide requires a comprehensive approach that extends beyond medication alone
In hypertensive postmenopausal women, a group characterized by high prevalence of endothelial dysfunction and accelerated declines in muscle mass, 4 weeks of CIT supplementation significantly improved superficial femoral artery flow-mediated dilation, and these vascular benefits were amplified when CIT was combined with slow-velocity, low-intensity resistance training
For patients with health conditions like heart disease who are starting treatment with any GLP-1 medication, close monitoring by healthcare providers is important
.jpg)
.webp)
